Moderate alcohol consumption as a cardiovascular risk factor: The role of homocysteine and the need to re-explain the 'French paradox'

Alcohol and Alcoholism

Volumn 36, Issue 3, 2001, Pages 185-188

  Badawy, A A B ^a  

^a WHITCHURCH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY THROMBOSIS; ATHEROSCLEROSIS; BEER; CARDIOVASCULAR RISK; DRINKING BEHAVIOR; EDITORIAL; HEALTH CARE POLICY; HEART PROTECTION; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; LIFESTYLE; MEDICAL RESEARCH; META ANALYSIS; MORTALITY; NONHUMAN; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PROTEIN INTAKE; PUBLIC HEALTH; RAT; RISK FACTOR; SMOKING; VITAMIN SUPPLEMENTATION; WINE;

EID: 0034993903     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/36.3.185     Document Type: Editorial

References (55)

1. Alcohol and risk of physical harm
2. Serum total homocysteine and coronary heart disease
3. Alcohol, cardiovascular diseases and all causes of death: A review of the epidemiological evidence
4. Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: A contradiction to the 'French paradox'
5. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
6. Folic acid - An innocuous means to reduce plasma homocysteine
7. 12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiency
8. 12 status
9. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients
10. Alcohol consumption, alcohol dependence, and the all-cause mortality
11. Are there net health benefits from moderate alcohol consumption? Morbidity and other parameters of health
12. The individual's drinking and degree of risk
13. Is alcohol really good for the heart?
14. Alcohol consumption and mortality. I. Characteristics of drinking groups
15. Is alcohol good for your health?
16. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
17. Homocystinemia: Vascular injury and arterial thrombosis
18. Homocystine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis
19. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons
20. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects
21. The spectrum of diseases of small coronary arteries and their physiologic consequences
22. Homocysteinemia due to folate deficiency
23. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease
24. Trends and geographical disparities in coronary heart disease in France: Are results concordant when different definitions of events are used?
25. Alcohol consumption and mortality. II. Studies of male populations
26. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase
27. The oxidant stress of hyperhomocyst(e)inemia
28. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
29. Homocysteine and coronary atherosclerosis
30. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
31. Homocysteine and vascular disease
32. Total plasma homocysteine and cardiovascular risk profile: The Hordaland Homocysteine Study
33. Plasma homocysteine levels and mortality in patients with coronary artery diseases
34. B vitamin supplementation lowers homocysteine levels in heart disease
35. Sensitivity of serum methylmalonic acid and total homocystine determinants for diagnosing cobalamin and folate deficiencies
36. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
37. Drinking after a heart attack
38. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry
39. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
40. Characterization of homocysteine metabolism in the rat liver
41. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
42. Induction of cyclin-A gene expression by homocysteine in vascular smooth muscle cells
43. 6 status on homocysteine metabolism
44. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy
45. Plasma homocysteine and cardiovascular disease
46. Total homocysteine in plasma or serum: Methods and clinical applications
47. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
48. Hormone replacement therapy may reduce high serum homocysteine in post-menopausal women
49. Folate and coronary heart disease
50. 6 nutrition status and cigarette smoking
51. Homocysteine and ischaemic heart disease: Results of a prospective study with implications on prevention
52. Homocysteine as a risk factor for cardiovascular and related disease: Nutritional implications
53. Homocysteine and atherothrombosis
54. Hyperhomocyst(e)inemia and atherothrombosis
55. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide